F50.0
Conditions
Interventions
Group 1: Patient workshop with discussions in small groups of n = 4 subjects each and in a total group of n = 8 on relevant endpoints to assess the efficacy / safety of (non-)pharmacological intervent
Sponsors
Universitätsklinikum Freiburg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Age: = 18 years; - Diagnosis: Anorexia nervosa as the main diagnosis, whereby an equal distribution (n = 4 each) of the anorexia subtypes restrictive type and binge-eating/purging type is aimed for as far as possible when recruiting the n = 8 subjects; - Weight: body mass index (BMI) = 15; - Based on the assessment of the clinicians involved: sufficient motivation for therapy and motivation to participate in the role of peer researcher in the workshop to support preparing the systematic review; - Availability of the signed declaration of consent for participation. Inclusion is independent of potential psychological comorbidities (e.g. depressive symptoms, obsessive-compulsive disorder) and independent of the number of previous treatments (e.g. outpatient/inpatient psychiatric treatment, psychotherapy, co-therapies). Specific inclusion criteria: Among the n = 8 planned subjects, recruitment of the following subgroups of patients is planned: - n = 3 patients undergoing ongoing inpatient or day-care treatment (day clinic) at the Department for Psychosomatic Medicine and Psychotherapy, Medical Center - University of Freiburg, Medical Faculty - University of Freiburg, Freiburg, Germany, with a treatment duration of at least four weeks; - n = 3 outpatients of the outpatient clinic of the Department for Psychosomatic Medicine and Psychotherapy; - n = 2 largely remitted patients who continue to have a low-frequency connection to the outpatient clinic of the Department for Psychosomatic Medicine and Psychotherapy.
Exclusion criteria
Exclusion criteria: - Age: <18 years; - Diagnosis: Anorexia nervosa is not the main diagnosis; - Weight: BMI < 15; - Based on the assessment of the clinicians involved: insufficient motivation for therapy or motivation to participate in the role of peer researcher in the workshop to support preparing the systematic review; - Failure to provide signed informed consent for participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Patient-relevant outcomes on the efficacy and safety of pharmacological and non-pharmacological interventions for the treatment of anorexia nervosa 2. Prioritization of these outcomes During the three-hour workshop, the workshop leaders note the summarized discussion results (i.e. the endpoints identified and prioritized as relevant by the small group or the whole group of participants; in case of the total group, the aggregated results of the small groups) in an Excel spreadsheet. No formal data collection (e.g. questionnaires, interviews, collection of biomaterial, etc.) is carried out. It is not possible to draw conclusions about the statements of individual participants. | — |
Countries
Germany
Contacts
Public ContactAngela Kunzler
Institut für Evidenz in der Medizin, Universitätsklinikum Freiburg, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Deutschland
Outcome results
None listed